[1]JournaloftheAmericanChemicalSociety,1994,vol.116,p.5057-5062
[2]ChemicalCommunications,2017,vol.53,p.713-715
[3]EuropeanJournalofMedicinalChemistry,2015,vol.102,p.153-166
[4]MedChemComm,2019,vol.10,p.1037-1041
[1]Patent:WO2015/179190,2015,A1
83277-23-0 | 2,4-Dichloro-3-methylbenzoic acid | AA004T01 | MFCD16659660
871332-84-2 | 3-(Methoxy(methyl)aminocarbonyl)-5-nitrophenylboronic acid | AA004TSL | MFCD07783876
83578-21-6 | 2-(Pyridin-2-yldisulfanyl)ethanamine | AA004UCQ | MFCD01863453
859850-75-2 | 1-Methyl-1H-indole-5-sulfonyl chloride | AA004VKU | MFCD08271907
828270-62-8 | 4-Fluoro-2-methyl-1-(methylsulfonyl)benzene | AA004WXC | MFCD04037935
85092-82-6 | 3-Bromo-5-chloro-1H-indole | AA004XKP | MFCD06410767
84697-14-3 | Benzene,1-(1,1-dimethylethoxy)-4-(2-methoxyethyl)- | AA004Z4O | MFCD30181853
81090-45-1 | 2,4-Dibromo-6-isopropylaniline | AA004ZYB | MFCD11845854
817181-75-2 | 2-Chloro-3-hexylthiophene | AA00515Y | MFCD18413738
845826-92-8 | 4-(5-Methylpyridin-2-yl)benzoic acid | AA00527N | MFCD08689899